Tingting Fang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tingting Fang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Dongyan Guan
Shandong Provincial Key Lab. of Animal Biotechnology and Disease Control and Prevention Lab of Aquatic Animal Nutrition & Environmental Health Shandong Agricultural University Taian City China
1 shared publicationHaojun Han
Shandong Provincial Key Lab. of Animal Biotechnology and Disease Control and Prevention Lab of Aquatic Animal Nutrition & Environmental Health Shandong Agricultural University Taian City China
1 shared publicationHuiwen Sun
Shandong Provincial Key Lab. of Animal Biotechnology and Disease Control and Prevention Lab of Aquatic Animal Nutrition & Environmental Health Shandong Agricultural University Taian City China
1 shared publication- Jiting Wang
Lab of Aquatic Animal Nutrition & Environmental Health, Department of Animal Science, Shandong Agricultural University, Tai’an, China
1 shared publication Lanqin Liu
Department of Pediatric Hematology, The Affiliated Hospital of Southwest Medical University
1 shared publication- Wenjun Liu
Department of Pediatric Hematologic Oncology and Respiratory Children's Medical Center, The Affiliated Hospital, Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Southwest Medical University Luzhou Sichuan P. R. China
1 shared publication
Latest Publications
- Open Access
- 21 March 2021
- Published by Wiley in Aquaculture Research
- Vol. 52 (8) , 3911-3922
Effects of rosiglitazone on growth and skeletal muscle glucose metabolism of GIFT tilapia based on PI3K/Akt signaling pathway
- 21 March 2021
- Published by Wiley in Aquaculture Research
- Vol. 52 (8) , 3911-3922
Open AccessEffects of rosiglitazone on growth and skeletal muscle glucose metabolism of GIFT tilapia based on PI3K/Akt signaling pathway
- Open Access
- 11 December 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (50) , e23546
Network pharmacology-based strategy for predicting therapy targets of Tripterygium wilfordii on acute myeloid leukemia
This is a study on the potential therapeutic targets and pharmacological mechanism of Tripterygium wilfordii (TW) in acute myeloid leukemia (AML) based on network pharmacology. Active components of TW were obtained by network pharmacology through oral bioavailability, drug-likeness filtration. Comparative analysis was used to investigate the overlapping genes between active ingredient's targets and AML treatment-related targets. Using STRING database to analyze interactions among overlapping genes. Both KEGG pathway analysis and Gene Ontology enrichment analysis were conducted in DAVID. These genes were analyzed for survival in OncoLnc database. We screened 53 active ingredients; the results of comparative analysis showed that 8 active ingredients had an effect on AML treatment. On the basis of the active ingredients and overlapping genes, we constructed the Drug-Compounds-Genes-Disease Network. Survival analysis of overlapping genes indicated that some targets possessed a significant influence on patients’ survival and prognosis. The enrichment analysis showed that the main pathways of targets were Toll-like receptor signaling pathway, NF-kappa B signaling pathway, and HIF-1 signaling pathway. This study, using a network pharmacologic approach, provides another strategy that can help us to understand the mechanisms by which TW treats AML comprehensively.
- 11 December 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (50) , e23546
Open AccessNetwork pharmacology-based strategy for predicting therapy targets of Tripterygium wilfordii on acute myeloid leukemia
This is a study on the potential therapeutic targets and pharmacological mechanism of Tripterygium wilfordii (TW) in acute myeloid leukemia (AML) based on network pharmacology. Active components of TW were obtained by network pharmacology through oral bioavailability, drug-likeness filtration. Comparative analysis was used to investigate the overlapping genes between active ingredient's targets and AML treatment-related targets. Using STRING database to analyze interactions among overlapping genes. Both KEGG pathway analysis and Gene Ontology enrichment analysis were conducted in DAVID. These genes were analyzed for survival in OncoLnc database. We screened 53 active ingredients; the results of comparative analysis showed that 8 active ingredients had an effect on AML treatment. On the basis of the active ingredients and overlapping genes, we constructed the Drug-Compounds-Genes-Disease Network. Survival analysis of overlapping genes indicated that some targets possessed a significant influence on patients’ survival and prognosis. The enrichment analysis showed that the main pathways of targets were Toll-like receptor signaling pathway, NF-kappa B signaling pathway, and HIF-1 signaling pathway. This study, using a network pharmacologic approach, provides another strategy that can help us to understand the mechanisms by which TW treats AML comprehensively.